Walgreens Boots Alliance (NASDAQ: WBA) reported Q3 EPS of $0.83, $0.38 worse than the analyst estimate of $1.21. Revenue for the quarter came in at $34.6 billion versus the consensus estimate of $34.44 billion.

GUIDANCE:

Walgreens Boots Alliance sees Q4 2020 EPS of $4.65-$4.75, versus the consensus of $5.42.

• The company introduced fiscal 2020 adjusted EPS guidance of $4.65 to $4.75, including estimated adverse COVID-19 impacts of $1.03 to $1.14 per share. This guidance assumes continued adverse impacts from COVID-19 in the fourth quarter. In the UK, retail conditions are expected to remain very depressed, despite gradual easing of restrictions. More robust sales growth is expected in the Retail Pharmacy USA division, although retail margins are expected to remain compressed in comparison to fiscal 2019. This guidance is based on sales trends the company saw in the month of June and does not factor in potential changes to those trends.

For earnings history and earnings-related data on Walgreens Boots Alliance (WBA) click here.